128 related articles for article (PubMed ID: 32732841)
1. Peripheral Donor-specific Antibodies Are Associated With Histology and Cellular Subtypes in Protocol Liver Biopsies of Pediatric Recipients.
Cousin VL; Rougemont AL; Rubbia-Brandt L; Wildhaber BE; Villard J; Ferrari-Lacraz S; McLin VA
Transplantation; 2020 Aug; 104(8):1633-1643. PubMed ID: 32732841
[TBL] [Abstract][Full Text] [Related]
2. Morphological characterization of chronic antibody-mediated rejection in ABO-identical or ABO-compatible pediatric liver graft recipients.
Dao M; Habès D; Taupin JL; Mussini C; Redon MJ; Suberbielle C; Jacquemin E; Gonzales E; Guettier C
Liver Transpl; 2018 Jul; 24(7):897-907. PubMed ID: 29704327
[TBL] [Abstract][Full Text] [Related]
3. Preformed and de novo DSA are associated with T-cell-mediated rejection in pediatric liver transplant recipients requiring clinically indicated liver biopsy.
Schluckebier D; Cousin VL; Petit LM; Belli D; Wildhaber B; Rougemont AL; Villard J; Ferrari-Lacraz S; McLin VA
Pediatr Transplant; 2020 Feb; 24(1):e13611. PubMed ID: 31682057
[TBL] [Abstract][Full Text] [Related]
4. DSA Are Associated With More Graft Injury, More Fibrosis, and Upregulation of Rejection-associated Transcripts in Subclinical Rejection.
Höfer A; Jonigk D; Hartleben B; Verboom M; Hallensleben M; Hübscher SG; Manns MP; Jaeckel E; Taubert R
Transplantation; 2020 Mar; 104(3):551-561. PubMed ID: 31651790
[TBL] [Abstract][Full Text] [Related]
5. Donor-specific HLA alloantibodies: Impact on cardiac allograft vasculopathy, rejection, and survival after pediatric heart transplantation.
Tran A; Fixler D; Huang R; Meza T; Lacelle C; Das BB
J Heart Lung Transplant; 2016 Jan; 35(1):87-91. PubMed ID: 26422083
[TBL] [Abstract][Full Text] [Related]
6. Late graft hepatitis and fibrosis in pediatric liver allograft recipients: Current concepts and future developments.
Kelly D; Verkade HJ; Rajanayagam J; McKiernan P; Mazariegos G; Hübscher S
Liver Transpl; 2016 Nov; 22(11):1593-1602. PubMed ID: 27543906
[TBL] [Abstract][Full Text] [Related]
7. Donor-Specific Antibodies in Pediatric Intestinal and Multivisceral Transplantation: The Role of Liver and Human Leukocyte Antigen Mismatching.
Talayero P; Ramos Boluda E; Gómez Massa E; Castro Panete MJ; Prieto Bozano G; Hernández Oliveros F; López Santamaría M; Calvo Pulido J; Paz-Artal E; Mancebo E
Liver Transpl; 2018 Dec; 24(12):1726-1735. PubMed ID: 30112820
[TBL] [Abstract][Full Text] [Related]
8. De Novo Donor-Specific Anti-Human Leukocyte Antigen Antibody Detection in Long-Term Adult Liver Transplantation.
San Segundo D; Alonso C; Ruiz P; Romon I; Arias-Loste MT; Cuadrado A; Puente A; Casafont F; López-Hoyos M; Crespo J; Fábrega E
Transplant Proc; 2016 Nov; 48(9):2980-2982. PubMed ID: 27932124
[TBL] [Abstract][Full Text] [Related]
9. Significance of central perivenulitis in pediatric liver transplantation.
Abraham SC; Freese DK; Ishitani MB; Krasinskas AM; Wu TT
Am J Surg Pathol; 2008 Oct; 32(10):1479-88. PubMed ID: 18708942
[TBL] [Abstract][Full Text] [Related]
10. Donor-specific HLA Antibodies Are Associated With Late Allograft Dysfunction After Pediatric Liver Transplantation.
Wozniak LJ; Hickey MJ; Venick RS; Vargas JH; Farmer DG; Busuttil RW; McDiarmid SV; Reed EF
Transplantation; 2015 Jul; 99(7):1416-22. PubMed ID: 26038872
[TBL] [Abstract][Full Text] [Related]
11. Preformed and de novo donor specific antibodies in visceral transplantation: long-term outcome with special reference to the liver.
Abu-Elmagd KM; Wu G; Costa G; Lunz J; Martin L; Koritsky DA; Murase N; Irish W; Zeevi A
Am J Transplant; 2012 Nov; 12(11):3047-60. PubMed ID: 22947059
[TBL] [Abstract][Full Text] [Related]
12. Five-year histological and serological follow-up of operationally tolerant pediatric liver transplant recipients enrolled in WISP-R.
Feng S; Demetris AJ; Spain KM; Kanaparthi S; Burrell BE; Ekong UD; Alonso EM; Rosenthal P; Turka LA; Ikle D; Tchao NK
Hepatology; 2017 Feb; 65(2):647-660. PubMed ID: 27302659
[TBL] [Abstract][Full Text] [Related]
13. Circulating donor-specific anti-HLA antibodies are a major factor in premature and accelerated allograft fibrosis.
Gosset C; Viglietti D; Rabant M; Vérine J; Aubert O; Glotz D; Legendre C; Taupin JL; Duong Van-Huyen JP; Loupy A; Lefaucheur C
Kidney Int; 2017 Sep; 92(3):729-742. PubMed ID: 28554738
[TBL] [Abstract][Full Text] [Related]
14. Development of de novo HLA donor specific antibodies (HLA-DSA), HLA antibodies (HLA-Ab) and allograft rejection post blood transfusion in kidney transplant recipients.
Jalalonmuhali M; Carroll RP; Tsiopelas E; Clayton P; Coates PT
Hum Immunol; 2020 Jul; 81(7):323-329. PubMed ID: 32327243
[TBL] [Abstract][Full Text] [Related]
15. Longterm renal allograft survival after sequential liver-kidney transplantation from a single living donor.
Kitajima K; Ogawa Y; Miki K; Kai K; Sannomiya A; Iwadoh K; Murakami T; Koyama I; Nakajima I; Fuchinoue S
Liver Transpl; 2017 Mar; 23(3):315-323. PubMed ID: 27862900
[TBL] [Abstract][Full Text] [Related]
16. Obliterative portal venopathy: A histopathologic finding associated with chronic antibody-mediated rejection in pediatric liver allografts.
Guerra MR; Naini BV; Scapa JV; Reed EF; Busuttil RW; Cheng EY; Farmer DG; Vargas JH; Venick RS; McDiarmid SV; Wozniak LJ
Pediatr Transplant; 2018 Mar; 22(2):. PubMed ID: 29363222
[TBL] [Abstract][Full Text] [Related]
17. C1q-binding DSA and allograft outcomes in pediatric kidney transplant recipients.
Hayde N; Solomon S; Caglar E; Ge J; Qama E; Colovai A
Pediatr Transplant; 2021 Mar; 25(2):e13885. PubMed ID: 33131194
[TBL] [Abstract][Full Text] [Related]
18. HLA, Non-HLA Antibodies, and Eplet Mismatches in Pediatric Liver Transplantation: Observations From a Small, Single-Center Cohort.
Ekong UD; Antala S; Bow L; Sese D; Morotti R; Rodriguez-Davalos M; Gan G; Deng Y; Emre SH
Exp Clin Transplant; 2019 Jan; 17(Suppl 1):6-17. PubMed ID: 30777518
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and Clinical Impact of Donor-Specific Alloantibody Among Intestinal Transplant Recipients.
Cheng EY; Everly MJ; Kaneku H; Banuelos N; Wozniak LJ; Venick RS; Marcus EA; McDiarmid SV; Busuttil RW; Terasaki PI; Farmer DG
Transplantation; 2017 Apr; 101(4):873-882. PubMed ID: 27490417
[TBL] [Abstract][Full Text] [Related]
20. Influence of preformed donor-specific antibodies and C4d on early liver allograft function.
Perera MT; Silva MA; Murphy N; Briggs D; Mirza DF; Neil DA
Scand J Gastroenterol; 2013 Dec; 48(12):1444-51. PubMed ID: 24131305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
